W. Su

发表

Biology of Human Tumors Activation of IL 6 / IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT 4 / NANOG Expression

Yu-Chih Wu, T. Ling, Yen-Hua Huang, 2014 .

Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer

Jaw-Yuan Wang, Ming-Yii Huang, Chun-Ming Huang, 2021, Cancers.

Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, Biomedicines.

Comparison of UGT1A1 Polymorphism as Guidance of Irinotecan Dose Escalation in RAS Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as the First-Line Therapy

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, Oncology research.

Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-Only

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, Cancer management and research.

Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, The Journal of international medical research.

MicroRNA-148a induces apoptosis and prevents angiogenesis with bevacizumab in colon cancer through direct inhibition of ROCK1/c-Met via HIF-1α under hypoxia

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, Aging.

Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review

Jaw-Yuan Wang, Ming-Yii Huang, Chun-Ming Huang, 2022, Frontiers in Oncology.

Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?

Jaw-Yuan Wang, Jen-Hao Yeh, Ching-wen Huang, 2022, Cancers.

Expression and regulation of alkaline phosphatases in human breast cancer MCF-7 cells.

G. Chang, Y. Chen, W. Su, 2000, European journal of biochemistry.

Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, Cells.

Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression

T. Tung, Yu-Chih Wu, T. Ling, 2015, Clinical Cancer Research.

Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling

Qi Zhang, T. Liang, X. Bai, 2014, Oncogene.

Malignant pleural effusion cells show aberrant glucose metabolism gene expression

Chi-Ying F. Huang, Chi-Hung Lin, V. Tseng, 2010, European Respiratory Journal.

Comparison of Next-Generation Sequencing and Polymerase Chain Reaction for Personalized Treatment-Related Genomic Status in Patients with Metastatic Colorectal Cancer

Yun-Ru Liu, Jaw-Yuan Wang, H. Tsai, 2022, Current issues in molecular biology.

Surgical Efficacy and Safety of Patients with Locally Advanced Gastric Cancer following Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2022, Journal of oncology.

miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting c-Met

Jaw-Yuan Wang, Ming-Yii Huang, H. Tsai, 2021, Biomedicines.

Identifying and clinically validating biomarkers for immunotherapy in colorectal cancer

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2023, Expert review of molecular diagnostics.

Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2023, Frontiers in Oncology.

Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2023, Journal of oncology.

Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2021, International journal of molecular sciences.

Effectiveness and Cost-Utility Analysis of Different Doses of Irinotecan Plus Bevacizumab in Patients With Metastatic Colorectal Cancer: A Long-Term and Prospective Cohort Study

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2022, Frontiers in Oncology.

Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomy

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2023, Oncology research.

Genomic and Metabolomic Landscape of Right-Sided and Left-Sided Colorectal Cancer: Potential Preventive Biomarkers

Jaw-Yuan Wang, Chung-ke Chang, Chien-Wei Lin, 2022, Cells.

Combination of arginine, glutamine, and omega-3 fatty acid supplements for perioperative enteral nutrition in surgical patients with gastric adenocarcinoma or gastrointestinal stromal tumor (GIST): A prospective, randomized, double-blind study

H. Tsai, W. Su, Y. Shih, 2018, Journal of postgraduate medicine.

Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in BRAFV600E-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational Study

H. Tsai, Yen-Cheng Chen, Tsung-Kun Chang, 2023, Medicina.

Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis

H. Tsai, Yen-Cheng Chen, Y. Yeh, 2023, World Journal of Surgical Oncology.